Answer
Yes, serious infections, including life-threatening or fatal infections, have occurred frequently after Kymriah (tisagenlecleucel) infusion, sometimes with late onset.
Sources for this answer
- Kymriah cells dispersion for infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 15Document updated
Sources checked